Fluorine‐18 labelling of oligonucleotides: Prosthetic labelling at the 5′‐end using the <i>N</i>‐(4‐[<sup>18</sup>F]fluorobenzyl)‐2‐bromoacetamide reagent

Bertrand Kühnast, Françoise Hinnen, R. Boisgard, Bertrand Tavitian, F. Dollé

Journal of Labelled Compounds and Radiopharmaceuticals · 2003 · 33 citations · 10 references

Concepts

Abstract

Abstract Labelled oligonucleotides are new imaging tools to study gene expression at the nucleic acid and protein levels. We have previously developed a universal method to label oligonucleotides at their 3′‐end with radiohalogens and particularly with fluorine‐18, the most widely used positron‐emitter, t 1/2 : 109.8 min. Using the same strategy, we herein report the fluorine‐18 labelling of oligonucleotides at their 5′‐end. A 18‐mer 2′O‐methyl modified oligoribonucleotide, bearing a phosphorothioate group at its 5′‐end, was conjugated to our fluorine‐18‐labelled reagent N ‐(4‐[ 18 F]fluorobenzyl)‐2‐bromoacetamide. The whole synthetic procedure yielded up to 1 GBq of fluorine‐18‐labelled oligonucleotide with a specific radioactivity of 37–74 GBq/μmol in 160 min. Copyright © 2003 John Wiley &amp; Sons, Ltd.

References

10